Understanding the genetic basis of resistance to EGFR targeted therapies to personalize colorectal cancer treatment

被引：0
|
作者：
Bardelli, A. [1 ,2 ]
机构：
[1] Univ Torino Med Sch, Mol Genet Lab, Inst Canc Res & Treatment, Candiolo, TO, Italy
[2] FIRC Inst Mol Oncol, Milan, Italy
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70062-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Acquired resistance to EGFR-targeted therapies in colorectal cancer
    Van Emburgh, Beth O.
    Sartore-Bianchi, Andrea
    Di Nicolantonio, Federica
    Siena, Salvatore
    Bardelli, Alberto
    MOLECULAR ONCOLOGY, 2014, 8 (06) : 1084 - 1094
  • [2] EGFR-Targeted therapies in colorectal cancer
    Overman, Michael J.
    Hoff, Paulo M.
    DISEASES OF THE COLON & RECTUM, 2007, 50 (08) : 1259 - 1270
  • [3] Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
    Leto, Simonetta M.
    Trusolino, Livio
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2014, 92 (07): : 709 - 722
  • [4] Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
    Simonetta M. Leto
    Livio Trusolino
    Journal of Molecular Medicine, 2014, 92 : 709 - 722
  • [5] Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients
    Riera, P.
    Rodriguez-Santiago, B.
    Lasa, A.
    Gonzalez-Quereda, L.
    Martin, B.
    Salazar, J.
    Sebio Garcia, A.
    Virgili Manrique, A. C.
    Surralles, J.
    Paez, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S434 - S434
  • [6] Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients
    Riera, Pau
    Rodriguez-Santiago, Benjamin
    Lasa, Adriana
    Gonzalez-Quereda, Lidia
    Martin, Berta
    Salazar, Juliana
    Sebio, Ana
    Virgili, Anna C.
    Minguillon, Jordi
    Camps, Cristina
    Surralles, Jordi
    Paez, David
    CANCERS, 2020, 12 (08) : 1 - 15
  • [7] Overcoming resistance to EGFR-targeted therapies in cancer
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (02) : 120 - 120
  • [8] Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer
    Lorenzato, Annalisa
    Magri, Alessandro
    Matafora, Vittoria
    Audrito, Valentina
    Arcella, Pamela
    Lazzari, Luca
    Montone, Monica
    Lamba, Simona
    Deaglio, Silvia
    Siena, Salvatore
    Bertotti, Andrea
    Trusolino, Livio
    Bachi, Angela
    Di Nicolantonio, Federica
    Bardelli, Alberto
    Arena, Sabrina
    CANCERS, 2020, 12 (03)
  • [9] Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just genetics
    Parseghian, Christine
    Eluri, Madhulika
    Kopetz, Scott
    Raghav, Kanwal
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [10] Combination of Targeted Therapies for Colorectal Cancer Treatment
    Peraudeau, Elodie
    Renoux, Brigitte
    Emambux, Sheik
    Poinot, Pauline
    Chatre, Remi
    Thoreau, Fabien
    Yaw, Benjamin Riss
    Tougeron, David
    Clarhaut, Jonathan
    Papot, Sebastien
    MOLECULAR PHARMACEUTICS, 2023, 20 (09) : 4537 - 4545
12345